NINDS Parkinson's Disease Neuroprotection Trial of CoQ10 and GPI 1485

PHASE2CompletedINTERVENTIONAL
Enrollment

195

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
Parkinson Disease
Interventions
DRUG

CoQ10

DRUG

GPI 1485

Trial Locations (1)

14620

University of Rochester Medical Center, Rochester

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

University of Rochester

OTHER

NCT00076492 - NINDS Parkinson's Disease Neuroprotection Trial of CoQ10 and GPI 1485 | Biotech Hunter | Biotech Hunter